Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/13307
Title: Assessment of proliferative responses to granulocyte-macrophage colony-stimulating factor (GM-CSF) in acute myeloid leukaemia using a fluorescent ligand for the nucleoside transporter.
Authors: Wiley, J S;Cebon, Jonathan S;Jamieson, Gary P;Szer, J;Gibson, J;Woodruff, R K;McKendrick, J J;Sheridan, W P;Biggs, J C;Snook, M B
Affiliation: Department of Haematology, Austin Hospital, Victoria, Australia.
Issue Date: 1-Jan-1994
Citation: Leukemia; 8(1): 181-5
Abstract: Nucleoside transporter expression has been linked to proliferation in a variety of haemopoietic cell types. Granulocyte-macrophage colony-stimulating factor (GM-CSF) was given for 72 h before commencing chemotherapy in 15 patients with relapsed or refractory acute myeloid leukaemia (AML) and in 11 patients serial bone marrows were taken for measurement of [3H]thymidine labelling index, Ki-67 positivity and maximal binding of 5-(SAENTA-x8)-fluorescein, a flow cytometry ligand which enumerates nucleoside transporter sites. GM-CSF caused proliferation of marrow myeloblasts in eight of 11 patients, while in three patients there was no change in proliferative indices. The expression of nucleoside transporters increased up to 4-fold in the myeloblasts from the patients showing a proliferative response to GM-CSF but there was no increase in transporters on the myeloblasts from the three non-responding patients. A close correlation was found between the fold increase in nucleoside transporter expression and the fold increase in labelling index of marrow myeloblasts (r = 0.86, n = 9, p < 0.01). In one patient with acute megakaryoblastic leukemia, GM-CSF caused parallel increases in labelling index, Ki-67 positivity and numbers of nucleoside transporters on peripheral blood blast cells. Thus induction of proliferation by cytokine increases the expression of nucleoside transporters on leukaemic myeloblasts studied in serial samples from the same source (bone marrow or blood). The suitability of 5-(SAENTA-x8)-fluorescein for two colour flow cytometric analysis allows the rapid enumeration of nucleoside transporters in the myeloblast compartment of heterogeneous marrow samples.
Internal ID Number: 8289485
URI: http://ahro.austin.org.au/austinjspui/handle/1/13307
URL: http://www.ncbi.nlm.nih.gov/pubmed/8289485
Type: Journal Article
Subjects: Acute Disease
Blood Proteins.analysis
Bone Marrow.drug effects
Bone Marrow Cells
Carrier Proteins.analysis
Cell Division.drug effects
Fluoresceins
Granulocyte-Macrophage Colony-Stimulating Factor.therapeutic use
Humans
Leukemia, Megakaryoblastic, Acute.drug therapy.pathology
Leukemia, Myeloid.drug therapy.pathology
Membrane Proteins.analysis
Nucleoside Transport Proteins
Purine Nucleosides
Thymidine.metabolism
Tritium
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.